|
|
Medication experience in the treatment of arthralgia syndrome based on data mining of Ren Zhai Zhi Zhi Fang Theory |
YANG Yue1 LI Lu2 YUAN Bo2 CUI Weilu3 GE Lin2 CAO Wei1 |
1.Wang Jing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China;
2.Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;
3.Beijing University of Chinese Medicine, Beijing 100029, China |
|
|
Abstract Objective To study Yang Shiying’s medication experience in treating arthralgia syndrome in Ren Zhai Zhi Zhi Fang Theory. Methods The internal prescription for the treatment of arthralgia syndrome in Ren Zhai Zhi Zhi Fang Theory was sorted out and entered into the traditional Chinese medicine inheritance computing platform V3.0 for statistics and analysis of medication rules, and the nature and flavour, channel tropism, efficacy, frequency, association rules and clustering of drugs were discussed. Results A total of 47 decoction for internal administration were recorded, with a total of 100 traditional Chinese medicines, most of which were warm, calm nature, sweet, pungent, and bitter flavour drugs. The drugs mainly returned to the spleen, heart, liver, and lung channels, and the effects were mostly to replenish deficiency, relieve superficies, warming interior, promote blood circulation, and remove blood stasis and so on. Twenty-three traditional Chinese medicines with drug frequency ≥six, 28 high-frequency drug combinations, 24 association rules between drugs were obtained, and four kinds of prescriptions were obtained by clustering. Conclusion Yang Shiying believes that the etiology and pathogenesis of arthralgia syndrome were mainly external evil invasion and internal positive deficiency; kidney cold and blood stasis; spleen injury and phlegm stagnation. The treatment of arthralgia syndrome is not only dispelling wind and eliminating dampness, but also paying attention to “kidney”, “spleen”, “phlegm” and “blood”, using the methods of warming kidney and nourishing blood, strengthening spleen and eliminating phlegm, warming meridian, and activating blood, taking into account both internal and external evil, which can provide certain reference and basis for clinical treatment of arthralgia syndrome.
|
|
|
|
|
[1] 肖士菊,季云润,张广中.胡希恕“利小便”“小发汗”法论治痹证及辨证经验[J].环球中医药,2019,12(1):142-144.
[2] 周仲英.中医内科学[M].2版.北京:中国中医药出版社,2007.
[3] 徐桂琴,刘健.《内经》关于痹病的认识探讨[J].世界中西医结合杂志,2013,8(1):1-3,88.
[4] 桂诗琪,于峥,屈伸,等.《仁斋直指方论》学术思想研究[J].中国中医基础医学杂志,2016,22(6):744-747.
[5] 林慧光.杨士瀛医学全书[M].北京:中国中医药出版社,2006.
[6] 陈静,李岚.基于数据挖掘探讨《景岳全书·小儿则古方》用药规律[J].浙江中医药大学学报,2021,45(10):1098-1103,1106.
[7] 徐道情,欧梁,黄维琛.基于中医传承辅助平台挖掘《仙授理伤续断秘方》治伤用药规律[J].中国中医骨伤科杂志,2020,28(11):26-29.
[8] 国家药典委员会.中华人民共和国药典[M].一部.北京:中国医药科技出版社,2015.
[9] 张仕衡,杨宇峰,石岩.痹证之病因病机理论框架结构研究[J].辽宁中医药大学学报,2020,22(11):54-56.
[10] 于志谋,张华东.路志正从“后天失养”述痹病发病机制探析[J].北京中医药,2016,35(8):742-744.
[11] 汤小荣,王琳,李艺彤,等.白术与苍术类别与效用探讨[J].新中医,2019,51(2):33-36.
[12] 段秀俊,刘培,叶花,等.多指标一测多评-响应曲面法优选蜜炙甘草的最佳炮制工艺[J].中草药,2020,51(2):364-371.
[13] 宁雪,杨振泳,王凤文,等.HPLC同时测定甘草及其炮制品中7种成分的含量[J].中药材,2020,43(9):2146-2150.
[14] 邓淑蓉,潘宇政.肉桂主要化学成分及药理作用研究概况[J].现代中西医结合杂志,2018,27(4):448-451.
[15] 刘医辉,杨世英,马伟林,等.当归药理作用的研究进展[J].中国当代医药,2014,21(22):192-193,196.
[16] 王凤龙,刘员,张来宾,等.当归抗炎镇痛作用研究进展[J].中国实验方剂学杂志,2021,27(15):197-209.
[17] 叶先文,夏澜婷,任洪民,等.白芍炮制的历史沿革及化学成分、药理作用研究进展[J].中草药,2020,51(7):1951-1969.
[18] 李丽萍,张杜娟,冯坤苗.白芍总苷治疗类风湿关节炎药理作用及机制研究进展[J].山东医药,2019,59(26):111-113.
[19] 张晓娟,张燕丽,左冬冬.川芎的化学成分和药理作用研究进展[J].中医药信息,2020,37(6):128-133.
[20] 辛国,李鑫,黄晓巍.防风化学成分及药理作用[J].吉林中医药,2018,38(11):1323-1325.
[21] 徐惠波,孙晓波,赵全成,等.羌活挥发油的药理作用研究[J].中草药,1991,22(1):28-30.
[22] 余欣然,曹峰,陈云志.白芍总苷在自身免疫性疾病中的运用进展[J].中医药学报,2019,47(1):127-130.
[23] 陆带果,王璐瑶,王贵红,等.白芍总苷胶囊联合硫酸羟氯喹治疗干燥综合征的临床效果[J].中国医药导报,2019, 16(36):115-118.
[24] 赵阳,刘素芳,苏亚双,等.白芍总苷对类风湿关节炎成纤维样滑膜细胞增殖和凋亡的影响及机制[J].世界中医药,2021,16(19):2881-2884.
[25] Liang CL, Jiang H, Feng W,et al. Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands+ Macrophages via Activating IL-4/STAT6/PD-L2 Signaling [J]. Front Immunol,2021,12:683249.
[26] Meng QL,Meng WT,Bian H,et al. Total glucosides of paeony protects THP-1 macrophages against monosodium urate-induced inflammation via MALAT1/miR-876-5p/NLRP3 signaling cascade in gouty arthritis [J]. Biomed Pharmacother,2021,138:111413. |
|
|
|